Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of injectable H889A for post-hemorrhoidectomy pain
CTR20262699Phase 2Active
- Sponsor
- Huizhong Jishi Biotechnology
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H889A in postoperative pain, sponsored by Huizhong Jishi Biotechnology. Started Jul 2026; status: active.
02
Drugs
H889A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20262699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262699.